With the robust growth of the healthcare market both in Asia and across the world, Delex Group aims to become a major player in the healthcare sector by developing more product ranges, secure more distribution rights, expand its local and global distribution channels, invest in manufacturers of healthcare products and providers of healthcare services.
Delex plans to further develop and secure patent rights to more critical care and health care products. The new products will also enable Delex to further expand its product offering and markets. Delex currently has 5 company owned brands for global markets and 3 of which holds Intellectual Property Office of the Philippines (IPOPH) approved trademarks.
Delex plans to secure distribution rights to more critical care and health care products. This will enable Delex to expand its product offerings and markets that will include a range of products for critical care and for the treatment of major illnesses such as diabetes, heart, and Covid-related diseases. In addition to these products, healthcare solutions will also be developed for immunity and anti-aging, including stem cells and probiotics. Expanding our product range and coverage will enable Delex to expand our markets and sales.
Delex plans to secure more distribution channels globally through our own sales team, appointing experienced distributors and forming strategic partnerships with healthcare providers. This will help accelerate the market expansion and sales of our products.
Delex plans to invest, acquire, and form strategic partnerships with distributors of healthcare products with wide existing distribution channels in each region or country globally. This will help fast track and accelerate the market expansion and sales of our products.
Delex plans to invest, acquire, or form strategic partnerships with manufacturers of critical care, healthcare, and Covid-related products. Delex will work with our manufacturer to develop and manufacture our own product range. This will enable Delex to reduce the cost of our products, offer competitive prices to our customers and expand our markets and eventually increase our sales and profits.
Delex plans to invest, acquire, or form strategic partnerships with healthcare providers such as hospitals, clinics, diagnostic centers, and Health Maintenance Organizations (HMO). This will enable us to supply our products for use directly to the patients and provide valuable research data and information to Delex on the performance of our products and to develop new in-demand products.
Delex Pharmacy was established in October 2021 to provide access to patients with quality and affordable medicines. Delex Pharmacy showcases a wide array of cost-effective, branded, and generic over-the-counter medicines, prescription drugs, and other health and wellness products.
Delex plans to further expand its online pharmacy business. Online pharmacy will enable the company to reach out to a much larger customer base, and in all corners of the country and the world. Customers may order and purchase the products online 24/7 and delivered through express delivery. Free Membership and special discount programs for members may be launched to further attract, build, and maintain large customer base.